Neurogenic Bladder: Epidemiology, Diagnosis, and Management.
Panicker JN.
Semin Neurol. 2020 Oct;40(5):569-579. doi: 10.1055/s-0040-1713876. Epub 2020 Oct 16.
Epidemiology and pathophysiology of neurogenic bladder after spinal cord injury.
Hamid R, Averbeck MA, Chiang H, Garcia A, Al Mousa RT, Oh SJ, Patel A, Plata M, Del Popolo G.
World J Urol. 2018 Oct;36(10):1517-1527. doi: 10.1007/s00345-018-2301-z. Epub 2018 May 11.
EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part I diagnostics and conservative treatment.
Stein R, Bogaert G, Dogan HS, Hoen L, Kocvara R, Nijman RJM, Quadackers JSLT, Rawashdeh YF, Silay MS, Tekgul S, Radmayr C.
Neurourol Urodyn. 2020 Jan;39(1):45-57. doi: 10.1002/nau.24211. Epub 2019 Nov 13.
Automated closed-loop stimulation to inhibit neurogenic bladder overactivity.
Majerus S, Nguyen C, Brose S, Nemunaitis G, Damaser M, Bourbeau DJ.
Proc Inst Mech Eng H. 2024 Jun;238(6):619-627. doi: 10.1177/09544119231172272. Epub 2023 May 2.
Treatment of neurogenic detrusor overactivity and overactive bladder with Botox (onabotulinumtoxinA): Development, insights, and impact.
Nitti V, Haag-Molkenteller C, Kennelly M, Chancellor M, Jenkins B, Schurch B.
Medicine (Baltimore). 2023 Jul 1;102(S1):e32377. doi: 10.1097/MD.0000000000032377.
Chapter 1: The conditions of neurogenic detrusor overactivity and overactive bladder.
Haab F.
Neurourol Urodyn. 2014 Jul;33 Suppl 3:S2-5. doi: 10.1002/nau.22636.
Pharmacotherapy for Pediatric Neurogenic Bladder.
Kroll P.
Paediatr Drugs. 2017 Oct;19(5):463-478. doi: 10.1007/s40272-017-0249-x.
Chapter 4: Guidelines for the diagnosis and treatment of overactive bladder (OAB) and neurogenic detrusor overactivity (NDO).
Nambiar A, Lucas M.
Neurourol Urodyn. 2014 Jul;33 Suppl 3:S21-5. doi: 10.1002/nau.22631.
Chapter 5: Clinical data in neurogenic detrusor overactivity (NDO) and overactive bladder (OAB).
Cruz F, Nitti V.
Neurourol Urodyn. 2014 Jul;33 Suppl 3:S26-31. doi: 10.1002/nau.22630.
Editorial Comment to Urodynamic efficacy of fesoterodine for the treatment of neurogenic detrusor overactivity and/or low compliance bladder.
Sekido N.
Int J Urol. 2020 Oct;27(10):905. doi: 10.1111/iju.14335. Epub 2020 Aug 7.
